Jane Street Group LLC Purchases 888,711 Shares of AXA Equitable Holdings Inc (NYSE:EQH)

Share on StockTwits

Jane Street Group LLC lifted its position in AXA Equitable Holdings Inc (NYSE:EQH) by 264.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,224,911 shares of the company’s stock after acquiring an additional 888,711 shares during the quarter. Jane Street Group LLC owned 0.25% of AXA Equitable worth $25,601,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. YorkBridge Wealth Partners LLC raised its holdings in AXA Equitable by 77.9% in the second quarter. YorkBridge Wealth Partners LLC now owns 1,242 shares of the company’s stock worth $26,000 after purchasing an additional 544 shares in the last quarter. Advisor Group Inc. raised its holdings in AXA Equitable by 38.4% in the second quarter. Advisor Group Inc. now owns 2,104 shares of the company’s stock worth $44,000 after purchasing an additional 584 shares in the last quarter. Metropolitan Life Insurance Co NY raised its holdings in AXA Equitable by 18.5% in the first quarter. Metropolitan Life Insurance Co NY now owns 5,765 shares of the company’s stock worth $116,000 after purchasing an additional 898 shares in the last quarter. Oregon Public Employees Retirement Fund raised its holdings in AXA Equitable by 3.5% in the first quarter. Oregon Public Employees Retirement Fund now owns 45,764 shares of the company’s stock worth $922,000 after purchasing an additional 1,564 shares in the last quarter. Finally, Gulf International Bank UK Ltd raised its holdings in AXA Equitable by 3.1% in the second quarter. Gulf International Bank UK Ltd now owns 51,973 shares of the company’s stock worth $1,086,000 after purchasing an additional 1,573 shares in the last quarter. Hedge funds and other institutional investors own 58.26% of the company’s stock.

A number of equities analysts have commented on the stock. Morgan Stanley reduced their target price on shares of AXA Equitable from $28.00 to $27.00 and set an “overweight” rating for the company in a report on Tuesday, August 20th. Wells Fargo & Co restated a “hold” rating and set a $22.00 price objective on shares of AXA Equitable in a report on Thursday, August 8th. Royal Bank of Canada set a $26.00 price objective on shares of AXA Equitable and gave the company a “buy” rating in a report on Friday, August 9th. Zacks Investment Research upgraded shares of AXA Equitable from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a report on Wednesday, August 14th. Finally, ValuEngine downgraded shares of AXA Equitable from a “hold” rating to a “sell” rating in a report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company’s stock. AXA Equitable currently has an average rating of “Hold” and a consensus target price of $23.88.

In related news, major shareholder Axa sold 6,000,000 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $20.85, for a total value of $125,100,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Mark Pearson bought 49,000 shares of the company’s stock in a transaction that occurred on Thursday, June 27th. The stock was purchased at an average price of $20.34 per share, for a total transaction of $996,660.00. The disclosure for this purchase can be found here. 0.16% of the stock is owned by corporate insiders.

Shares of EQH traded up $0.43 during mid-day trading on Friday, hitting $22.62. 5,362,313 shares of the company traded hands, compared to its average volume of 2,092,018. AXA Equitable Holdings Inc has a 1-year low of $14.72 and a 1-year high of $22.93. The company has a market capitalization of $10.86 billion, a PE ratio of 5.81, a price-to-earnings-growth ratio of 0.67 and a beta of 1.36. The business has a 50 day moving average of $20.83 and a 200 day moving average of $21.28.

AXA Equitable (NYSE:EQH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.03 by $0.11. The company had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.22 billion. The business’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.90 EPS. On average, sell-side analysts predict that AXA Equitable Holdings Inc will post 4.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, August 29th. Investors of record on Thursday, August 22nd were given a $0.15 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $0.60 dividend on an annualized basis and a yield of 2.65%. AXA Equitable’s dividend payout ratio is currently 15.42%.

About AXA Equitable

AXA Equitable Holdings, Inc operates as a diversified financial services company worldwide. It operates through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals.

See Also: Momentum Indicators

Want to see what other hedge funds are holding EQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AXA Equitable Holdings Inc (NYSE:EQH).

Institutional Ownership by Quarter for AXA Equitable (NYSE:EQH)

Receive News & Ratings for AXA Equitable Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA Equitable and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bank of America Boosts Bristol-Myers Squibb  Price Target to $50.00
Bank of America Boosts Bristol-Myers Squibb Price Target to $50.00
Evoqua Water Technologies  Given New $14.00 Price Target at JPMorgan Chase & Co.
Evoqua Water Technologies Given New $14.00 Price Target at JPMorgan Chase & Co.
Altice USA  Earns “Buy” Rating from Pivotal Research
Altice USA Earns “Buy” Rating from Pivotal Research
Celanese  Price Target Increased to $120.00 by Analysts at SunTrust Banks
Celanese Price Target Increased to $120.00 by Analysts at SunTrust Banks
Pure Gold Mining  Shares Up 8.9%
Pure Gold Mining Shares Up 8.9%
Global X Autonomous & Electric Vehicles ETF  Stock Crosses Above Two Hundred Day Moving Average of $13.17
Global X Autonomous & Electric Vehicles ETF Stock Crosses Above Two Hundred Day Moving Average of $13.17


© 2006-2019 Ticker Report